These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 23255729)

  • 1. Sustained availability of 99mTc: possible paths forward.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2013 Feb; 54(2):313-23. PubMed ID: 23255729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molybdenum-99 production from reactor irradiation of molybdenum targets: a viable strategy for enhanced availability of technetium-99m.
    Pillai MR; Knapp FF
    Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):385-99. PubMed ID: 23013668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diversification of 99Mo/99mTc separation: non–fission reactor production of 99Mo as a strategy for enhancing 99mTc availability.
    Pillai MR; Dash A; Knapp FF
    J Nucl Med; 2015 Jan; 56(1):159-61. PubMed ID: 25537991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99Mo/(99m)Tc separation: an assessment of technology options.
    Dash A; Knapp FF; Pillai MR
    Nucl Med Biol; 2013 Feb; 40(2):167-76. PubMed ID: 23142410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diversification in the Supply Chain of (99)Mo Ensures a Future for (99m)Tc.
    Cutler CS; Schwarz SW
    J Nucl Med; 2014 Jul; 55(7):1208-13. PubMed ID: 24854794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alternative production methods to face global molybdenum-99 supply shortage.
    Lyra M; Charalambatou P; Roussou E; Fytros S; Baka I
    Hell J Nucl Med; 2011; 14(1):49-55. PubMed ID: 21512666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of radionuclidic impurities in cyclotron produced (99m)Tc.
    Lebeda O; van Lier EJ; Štursa J; Ráliš J; Zyuzin A
    Nucl Med Biol; 2012 Nov; 39(8):1286-91. PubMed ID: 22796396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility studies towards future self-sufficient supply of the (99)Mo-(99m)Tc isotopes with Japanese accelerators.
    Nakai K; Takahashi N; Hatazawa J; Shinohara A; Hayashi Y; Ikeda H; Kanai Y; Watabe T; Fukuda M; Hatanaka K
    Proc Jpn Acad Ser B Phys Biol Sci; 2014; 90(10):413-21. PubMed ID: 25504230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a 99Mo/99mTc generator using alumina microspheres for industrial radiotracer applications.
    Dash A; Chakravarty R; Ram R; Pillai KT; Yadav YY; Wagh DN; Verma R; Biswas S; Venkatesh M
    Appl Radiat Isot; 2012 Jan; 70(1):51-8. PubMed ID: 21820904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclotron production of (99m)Tc: experimental measurement of the (100)Mo(p,x)(99)Mo, (99m)Tc and (99g)Tc excitation functions from 8 to 18 MeV.
    Gagnon K; Bénard F; Kovacs M; Ruth TJ; Schaffer P; Wilson JS; McQuarrie SA
    Nucl Med Biol; 2011 Aug; 38(6):907-16. PubMed ID: 21843787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of Multi-Curie Production of (99m)Tc by Conventional Medical Cyclotrons.
    Bénard F; Buckley KR; Ruth TJ; Zeisler SK; Klug J; Hanemaayer V; Vuckovic M; Hou X; Celler A; Appiah JP; Valliant J; Kovacs MS; Schaffer P
    J Nucl Med; 2014 Jun; 55(6):1017-22. PubMed ID: 24722529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 14 MeV Neutrons for
    Capogni M; Pietropaolo A; Quintieri L; Angelone M; Boschi A; Capone M; Cherubini N; De Felice P; Dodaro A; Duatti A; Fazio A; Loreti S; Martini P; Pagano G; Pasquali M; Pillon M; Uccelli L; Pizzuto A
    Molecules; 2018 Jul; 23(8):. PubMed ID: 30060449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclotron production of
    Gumiela M
    Nucl Med Biol; 2018 Mar; 58():33-41. PubMed ID: 29331921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of (99m)Tc from a commercial (99)Mo/(99m)Tc generator as yield tracer for the determination of (99)Tc at low levels.
    Hou X; Jensen M; Nielsen SP
    Appl Radiat Isot; 2007 May; 65(5):610-8. PubMed ID: 17350274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent achievements in Tc-99m radiopharmaceutical direct production by medical cyclotrons.
    Boschi A; Martini P; Pasquali M; Uccelli L
    Drug Dev Ind Pharm; 2017 Sep; 43(9):1402-1412. PubMed ID: 28443689
    [No Abstract]   [Full Text] [Related]  

  • 16. [Technetium-99m production for use in nuclear medicine].
    Vucina J
    Med Pregl; 2000; 53(11-12):631-4. PubMed ID: 11320753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production optimization of 99Mo/99mTc zirconium molybate gel generators at semi-automatic device: DISIGEG.
    Monroy-Guzman F; Rivero Gutiérrez T; López Malpica IZ; Hernández Cortes S; Rojas Nava P; Vazquez Maldonado JC; Vazquez A
    Appl Radiat Isot; 2012 Jan; 70(1):103-11. PubMed ID: 22001414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential Ways to Address Shortage Situations of
    Filzen LM; Ellingson LR; Paulsen AM; Hung JC
    J Nucl Med Technol; 2017 Mar; 45(1):1-5. PubMed ID: 28154015
    [No Abstract]   [Full Text] [Related]  

  • 19. Molybdenum-99/technetium-99m management: race against time.
    Ahmad M
    Ann Nucl Med; 2011 Nov; 25(9):677-9. PubMed ID: 21728046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclotron Production of (99m)Tc using (100)Mo2C targets.
    Richards VN; Mebrahtu E; Lapi SE
    Nucl Med Biol; 2013 Oct; 40(7):939-45. PubMed ID: 23890695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.